Troleandomycin | |
---|---|
Trade Name | |
Orphan Indication | Severe steroid-requiring asthma |
USA Market Approval | USA |
USA Designation Date | 1989-09-21 00:00:00 |
Sponsor | Szefler, Stanley M. M.D.;National Jewish Center for Immunology and Respirat, 1400 Jackson Street;Denver, Colorado, 80206 |